相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of Yttrium-90 transarterial radioembolization in patients with non-surgical hepatocellular carcinoma: A systematic review and meta-analysis
Simon Lemieux et al.
PLOS ONE (2021)
Liver resection versus transarterial chemoembolization for huge hepatocellular carcinoma: a propensity score matched analysis
A. Bogdanovic et al.
SCIENTIFIC REPORTS (2021)
Efficacy and safety of selective internal radiation therapy with yttrium-90 for the treatment of unresectable hepatocellular carcinoma
Nguyen Van Thai et al.
BMC GASTROENTEROLOGY (2021)
2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
Joong-Won Park et al.
GUT AND LIVER (2019)
Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: A meta-analysis of high-quality studies
Myung Han Hyun et al.
HEPATOLOGY (2018)
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
Pierce K. H. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma
Robert J. Lewandowski et al.
RADIOLOGY (2018)
Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma
Ahmed Gabr et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Jeong Eun Song et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valerie Vilgrain et al.
LANCET ONCOLOGY (2017)
Selective internal radiation therapy using yttrium-90 resin microspheres in patients with unresectable hepatocellular carcinoma: a retrospective study
Parvez S. Mantry et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2017)
Radioembolization for the treatment of hepatocellular carcinoma
Hyo-Cheol Kim
CLINICAL AND MOLECULAR HEPATOLOGY (2017)
Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality
Do Young Kim et al.
HEPATOLOGY INTERNATIONAL (2016)
The Adverse Effects of Sorafenib in Patients with Advanced Cancers
Ye Li et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2015)
Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization
R. Ciria et al.
EJSO (2015)
Treatment of hepatocellular carcinoma: Steps forward but still a long way to go
Liat Mlynarsky et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
R. Golfieri et al.
BRITISH JOURNAL OF CANCER (2014)
Unresectable Solitary Hepatocellular Carcinoma Not Amenable to Radiofrequency Ablation: Multicenter Radiology-Pathology Correlation and Survival of Radiation Segmentectomy
Michael Vouche et al.
HEPATOLOGY (2014)
Transarterial Chemoembolization and Radioembolization
Bruno Sangro et al.
SEMINARS IN LIVER DISEASE (2014)
Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis
Mi Sung Park et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Clinical Application of Liver Stiffness Measurement Using Transient Elastography: A Surgical Perspective
Seung Up Kim et al.
DIGESTION (2013)
Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma
Myeong Jun Song et al.
JOURNAL OF HEPATOLOGY (2012)
Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Riad Salem et al.
GASTROENTEROLOGY (2011)
Hepatic Resection versus Transarterial Lipiodol Chemoembolization as the Initial Treatment for Large, Multiple, and Resectable Hepatocellular Carcinomas: A Prospective Nonrandomized Analysis
Jun Luo et al.
RADIOLOGY (2011)
Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes
Riad Salem et al.
GASTROENTEROLOGY (2010)
Radioembolization with Yttrium-90 Glass Microspheres in Hepatocellular Carcinoma: European Experience on Safety and Long-Term Survival
Philip Hilgard et al.
HEPATOLOGY (2010)
Time-dependent analysis of predisposing factors for the recurrence of hepatocellular carcinoma
Shouta Iwadou et al.
LIVER INTERNATIONAL (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Safety and efficacy of Y-90 radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis
Laura M. Kulik et al.
HEPATOLOGY (2008)
Radioembolization with 90Y microspheres:: Angiographic and technical considerations
Robert J. Lewandowski et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2007)
Medical progress: Strategies for safer liver surgery and partial liver transplantation
Pierre-Alain Clavien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
分享论文
